Health Populi

JUNE 30, 2023

Since 2019, we can see the hockey-stick increase in the price of specialty drugs fast-growing. We’re living in/through and must plan for these ongoing changes, whether we work in provider organizations, health plans, pharma and life science companies, and to be sure, technology and retail/health organizations.

Mental health 211

Mental health Life Science Pharmaceuticals Telehealth 211

Health Populi

APRIL 24, 2019

The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. “informed public” and the mass population. health consumers.

BioTech 207

BioTech Pharmaceuticals Life Science Health Information 207

Digital Health Global

SEPTEMBER 28, 2023

” About Debiopharm Innovation Fund Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and guidance for companies with an ambition to improve the patient journey and transform pharmaceutical R&D.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Health Populi

MAY 4, 2023

Shown here in the third chart, note that adult vaccinations have returned to pre-COVID levels, but immunizations for kids were 20% lower than in 2019. IQVIA’s national prescription data revealed that prescriptions for mental health drugs grew 8% since 2019 — with a 33% rise among girls under 19.

Public Health 156

Public Health Mental health Life Science Telehealth 156

Health Populi

MARCH 28, 2022

I wrote about the company’s approach to food-as-medicine here in Health Populi in 2019 when Kroger Health began to message and market itself as a trusted health and wellness destination, Health Populi’s Hot Points: Over the 3 decades I’ve advised health care stakeholders across the ecosystem, I’ve benefited from working with (..)

Life Science 280

Life Science mHealth Primary Care Pharmaceuticals 280

Health Populi

OCTOBER 15, 2019

consumers age 18 and over in August and September 2019. One-third of these patients had a health care bill go to collections in the past year, according to Cedar’s 2019 U.S. And this is not only for providers and plans, but for pharma and life science companies, as well. Healthcare Consumer Experience Study.

Medical Billing 240

Medical Billing Life Science Medicare Pharmaceuticals 240

Lloyd Price

DECEMBER 11, 2023

Transforming healthcare A report from the London School of Economics, The Role of Virtual Health Care and the Pharmaceutical Sector in Improving Population Health , published in 2021, forecast that the pharmaceutical industry would be a core player in all aspects from population health management to preventive and therapeutic care.

Pharmaceuticals 61

Pharmaceuticals Digital Health Drug Development Life Science 61

Lloyd Price

JULY 13, 2018

Japan, one of the most advanced, high-tech countries in the world, is the third-biggest pharmaceuticals market, behind only the USA and China, and it is larger than France and Germany’s pharma sectors combined. Source : [link]

Pharmaceuticals 40

Pharmaceuticals Life Science 40

Health Populi

NOVEMBER 19, 2019

In the past decade, I’ve been spending a lot of time considering SDoH through a variety of lenses across the health/care ecosystem, including care providers like hospitals, health insurance companies, pharma and life science, retail health care front doors, and non-profits and foundations.

Medicare 149

Medicare Life Science Leadership Pharmaceuticals 149

Health Populi

SEPTEMBER 1, 2020

That six in ten oncologists perceived patient access programs are helpful in the pandemic is important because new oncologics launched in 2020 can be priced an average of $149,000 according to the 2019 forecast from IQVIA. Financial toxicity is a common side-effect for specialty drugs, and as U.S.

General practice 314

General practice Mental health Patient Experience Telemedicine 314

Henry Kotula

JULY 1, 2019

Thirty-eight percent of large employers offered a worksite clinic in 2019, up from 27 percent in 2014. The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. WHAT ELSE YOU SHOULD KNOW.

Life Science 32

Life Science Pharmaceuticals Mental health Telemedicine 32

Lloyd Price

FEBRUARY 6, 2019

These examples point to a broader shift in life sciences and health care that is only beginning to form and signal a new future of health. I expect the pace of innovation in this sector is going to accelerate in 2019. Doug Beaudoin, vice chairman, US Life Sciences & Health Care leader, Deloitte LLP Source : [link]

Life Science 57

Life Science Interoperability EMR Pharmaceuticals 57

Docnotes

JANUARY 27, 2020

We had a small team that worked closely with pharmaceutical companies and generated revenue from these relationships. I wasn’t very involved with this team, but due to my ownership of many of the clinical decision support initiatives, I started getting invited to meetings we had with pharmaceutical companies.

Pharmaceuticals 40

Pharmaceuticals EHR Life Science Pain management 40

Lloyd Price

APRIL 22, 2023

Femtech products and services can range from wearable devices, mobile apps, and online platforms to diagnostic tools, medical devices, and pharmaceuticals. In 2019, Progyny went public on the NASDAQ stock exchange, raising $93 million in its initial public offering (IPO). What’s driving FemTech’s growth?

Telemedicine 83

Telemedicine Life Science Pharmaceuticals Mental health 83

Digital Health Global

JANUARY 18, 2023

“Adding Blackford and its AI technology to our radiology portfolio secures Bayer an excellent position in the fastest growing segment within the overall global radiology industry,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceutical Division. 2019 Feb;18(1):e12861. Aging Cell.

Life Science 167

Life Science Pharmaceuticals Digital Health healthcare technology 167

Health Populi

OCTOBER 8, 2019

The study reviewed reports and articles published between January 1, 2012 and May 15, 2019, dressing the topic of waste across six domains previously identified by the Institute of Medicine: Failure of care delivery, with waste ranging between $102 bn and $166 bn.

Pharmaceuticals 267

Pharmaceuticals Medicare Life Science Health Policy 267

Lloyd Price

JULY 30, 2023

Pharmaceuticals: The pharmaceutical market is also a potential target for private equity rollups. Private equity firms could acquire small, innovative pharmaceutical companies and merge them together to create larger, more diversified pharmaceutical companies. There are a number of factors that are driving this trend.

Pharmaceuticals 52

Pharmaceuticals Life Science Telehealth healthcare technology 52

Healthcare IT Today

NOVEMBER 15, 2022

PEP Health showed that patient experience scores are on the rise for hospitals in Texas , with Stars Ratings steadily increasing since 2019. Teva Pharmaceuticals is partnering with Healthsnap and Rimidi to increase patient access to the Digihaler system.

Psychiatry 91

Psychiatry Digital Health Healthcare IT Mental health 91

Health Populi

APRIL 30, 2021

In the ten developed countries in the IQVIA Institute forecast, oncology has the greatest burden of disease, spending for which increased at a rate of 14% annually looking back to 2010 to 2019. Going forward 2021 to 2025, shown here, we can expect oncology to grow by between 9% and 12% globally.

Pharmaceuticals 156

Pharmaceuticals Mental health Medicare Life Science 156

Healthcare IT Today

MARCH 12, 2023

Since 2019, visit volume increased the most for diagnoses of eating disorders (at 53%), anxiety (48%), substance use disorders (27%), and depression (24%). Pharmaceutical and lab distributor Cardinal Health is collaborating with Signify Health to offer in-home clinical and medication management services.

Telemedicine 91

Telemedicine HIE Life Science Telehealth 91

Health Populi

FEBRUARY 22, 2021

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. Right now they’re very science- and research-forward versus very business-forward.”. Why was this the case?

Life Science 386

Life Science Pharmaceuticals Public Health BioTech 386

Health Populi

MARCH 6, 2019

There’s little Americans, by political party, agree upon in 2019. The Kaiser Family Foundation has been tracking this topic for a few years, and this month, their March 2019 Health Tracking Poll shows vast majorities of Democrats, Independents and Republicans all share these sentiments. consumers were asked.

Pharmaceuticals 145

Pharmaceuticals Life Science Medicare BioTech 145

Health Populi

JUNE 18, 2020

A Kaiser Family Foundation poll covered here in Health Populi demonstrated support across party ID back in October 2019. bn between 2019 and 2015 (Part D) and from $4.8 consumers have been supportive of government negotiation for drug pricing since well before the COVID-19 pandemic. Gallup and West Health polled 1,016 U.S. bn to $32.8

BioTech 195

BioTech Medicare Life Science Telehealth 195

Health Populi

FEBRUARY 4, 2020

voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Last year, IQVIA estimated a median price for new oncologics in 2019 was $149,000. Few issues unite U.S.

Pharmaceuticals 201

Pharmaceuticals Medicare Leadership Life Science 201

Health Populi

MAY 19, 2019

This poll from RealClear Politics , conducted in late April/early May 2019, makes my point that the patient is the consumer and, facing deductibles and more financial exposure to footing the medical bill, the payor.

Life Science 154

Life Science BioTech Medicare Medical Billing 154